Market Overview:
The global carbohydrate antigen 19-9 quantitative determination kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of pancreatic cancer, rising demand for early diagnosis and treatment of pancreatic cancer, and technological advancements in the field of immunoassays. However, the high cost associated with these kits may restrain the growth of this market during the forecast period. Based on type, the global carbohydrate antigen 19-9 quantitative determination kit market is segmented into chemiluminescence immunoassay and time-resolved immunoassay. The chemiluminescence immunoassay segment is expected to account for a larger share of this market during the forecast period owing to its advantages such as high sensitivity and specificity, short assay time, low sample volume requirement, and ease of use. Based on application, the global carbohydrate antigen 19-9 quantitative determination kit market is segmented into hospital and clinic.
Product Definition:
The Carbohydrate Antigen 19-9 Quantitative Determination Kit is a quantitative assay kit used to measure the level of carbohydrate antigen 19-9 in a sample. The importance of this kit is that it can help to diagnose and monitor pancreatic cancer.
Chemiluminescence Immunoassay:
Chemiluminescence immunoassay (CLIA) is a technique used for the quantitative determination of an analyte in biological fluids and tissues. It utilizes the principle that light energy released by the chemical reaction between a labeled compound and antibodies or antigen causes lightening. The intensity of light depends on the quantity of analyte present in sample.
Time-resolved Immunoassay:
Time-resolved immunoassay (TRIA) is a technique that measures the amount of an antigen in the patient's body without using any antibodies. It uses a sensitive detector molecule, usually made from organic compounds such as enzymes and prosthetic groups. The TRIA process involves detecting an immune response to the antigen within specific time limits.
Application Insights:
The market is categorized based on the application of the test kit as hospital, clinic or home testing. The hospital application dominated the overall revenue in 2017 owing to an increase in cancer cases globally and a rise in demand for rapid diagnostic tests. Moreover, rising awareness about early detection of diseases is further anticipated to boost growth over the forecast period.
Clinic applications are expected to witness significant growth during the study period owing to an increase in demand for faster and accurate diagnosis across various end-use industries such as diagnostics, pharmaceuticals and research laboratories. Furthermore, growing investments by companies such as Amgen Inc., Quest Diagnostics Inc., Laboratory Corporation of America Holdings LLC (LabCorp) and others are expected to drive industry expansion over next seven years with respect to product adoption rate among clinics/hospitals.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of diagnostic laboratories, rising prevalence of cancer and diabetes, and availability of advanced healthcare facilities in this region. Moreover, increasing government initiatives for cancer screening programs are also expected to boost demand for CAG testing over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to growing target population base with high risk factors such as obesity and chronic diseases associated with carbohydrate antigen 19-9 levels; improving healthcare infrastructure; rising awareness about early diagnosis; and increasing disposable income especially in developing countries like China & India. These aforementioned factors are expected to drive regional market growth during the forecast period from 2018 To 2030 (estimated).
Growth Factors:
- Increasing prevalence of cancer
- Rising demand for early diagnosis and treatment of cancer
- Technological advancements in the field of immunoassays
- Growing awareness about CA 19-9 tumor marker among patients and healthcare professionals
- Increasing number of clinical studies on CA 19-9 tumor marker
Scope Of The Report
Report Attributes
Report Details
Report Title
Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Research Report
By Type
Chemiluminescence Immunoassay, Time-resolved Immunoassay
By Application
Hospital, Clinic
By Companies
Innodx, Daan, Bioscience, BGI, Chivd, Fujirebio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
147
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Report Segments:
The global Carbohydrate Antigen 19-9 Quantitative Determination Kit market is segmented on the basis of:
Types
Chemiluminescence Immunoassay, Time-resolved Immunoassay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Innodx
- Daan
- Bioscience
- BGI
- Chivd
- Fujirebio
Highlights of The Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemiluminescence Immunoassay
- Time-resolved Immunoassay
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Carbohydrate Antigen 19-9 Quantitative Determination Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Carbohydrate Antigen 19-9 Quantitative Determination Kit is a laboratory test that determines the amount of carbohydrate antigen 19-9 in a sample.
Some of the key players operating in the carbohydrate antigen 19-9 quantitative determination kit market are Innodx, Daan, Bioscience, BGI, Chivd, Fujirebio.
The carbohydrate antigen 19-9 quantitative determination kit market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Carbohydrate Antigen 19-9 Quantitative Determination Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Carbohydrate Antigen 19-9 Quantitative Determination Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Size & Forecast, 2020-2028
4.5.1 Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Size and Y-o-Y Growth
4.5.2 Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chemiluminescence Immunoassay
5.2.2 Time-resolved Immunoassay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Carbohydrate Antigen 19-9 Quantitative Determination Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chemiluminescence Immunoassay
9.6.2 Time-resolved Immunoassay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chemiluminescence Immunoassay
10.6.2 Time-resolved Immunoassay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chemiluminescence Immunoassay
11.6.2 Time-resolved Immunoassay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chemiluminescence Immunoassay
12.6.2 Time-resolved Immunoassay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chemiluminescence Immunoassay
13.6.2 Time-resolved Immunoassay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Carbohydrate Antigen 19-9 Quantitative Determination Kit Market: Competitive Dashboard
14.2 Global Carbohydrate Antigen 19-9 Quantitative Determination Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Innodx
14.3.2 Daan
14.3.3 Bioscience
14.3.4 BGI
14.3.5 Chivd
14.3.6 Fujirebio
